Aveanna healthcare holdings sees $606,940 in stock sales by major owner

Published 16/05/2025, 20:58
Aveanna healthcare holdings sees $606,940 in stock sales by major owner

Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), a healthcare company with a market capitalization of $1.17 billion, witnessed significant stock sales by a major shareholder, Robert M. Williams Jr., according to recent filings. Over two days, May 14 and 15, Williams sold shares worth approximately $606,940. The transactions were executed at prices ranging from $5.88 to $5.89 per share, close to the stock’s 52-week high of $6.19.

The sales were conducted through various entities associated with Williams, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC. These transactions reduced Williams’ direct and indirect holdings in Aveanna Healthcare, which has seen remarkable performance with a 126% return over the past year. InvestingPro analysis reveals the stock is currently trading at Fair Value, with 11 additional exclusive insights available to subscribers.

The sales were part of a pre-established trading plan under Rule 10b5-1, which was adopted in December 2024. This rule allows insiders to set up a predetermined schedule for selling stocks, helping to avoid potential insider trading accusations.

Following these transactions, Williams continues to hold a substantial number of shares through indirect ownership, reflecting his ongoing interest in the company’s performance.

In other recent news, Aveanna Healthcare Holdings Inc. reported impressive financial results for the first quarter of 2025. The company achieved earnings per share of $0.10, surpassing the anticipated loss of $0.0014. Revenue for the quarter reached $559 million, significantly exceeding the forecast of $513.7 million. This strong performance reflects the company’s effective cost management and strategic growth initiatives. Additionally, Aveanna projects its 2025 revenue to exceed $2.15 billion, with an adjusted EBITDA projection of over $270 million.

In another development, Aveanna Healthcare announced the results of its 2025 Annual Meeting of Stockholders. The stockholders voted on several proposals, including the election of directors and the ratification of the company’s independent auditor, Ernst & Young LLP. All proposals were approved, indicating continued stockholder confidence in the company’s leadership.

Furthermore, Aveanna Healthcare is set to expand its operations through the acquisition of ThriveSkilled Pediatrics, which is expected to enhance the company’s preferred payer and government affairs strategies. This acquisition aligns with Aveanna’s goal of increasing its footprint in key states and strengthening its partnerships. These recent developments underscore Aveanna’s ongoing efforts to drive growth and improve financial performance in a challenging healthcare environment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.